Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?

Affiliations

¹ Department of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Michigan, Ann Arbor, MI.
² Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA. Electronic address: arjunmohanmd@gmail.com.

Editorial

Njira Lugogo et al. Chest. 2022 Jul.

. 2022 Jul;162(1):4-5.

doi: 10.1016/j.chest.2022.04.004.

¹ Department of Internal Medicine, Division of Pulmonary & Critical Care Medicine, University of Michigan, Ann Arbor, MI.
² Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA. Electronic address: arjunmohanmd@gmail.com.

No abstract available

Comment on

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial.
Sher LD, Wechsler ME, Rabe KF, Maspero JF, Daizadeh N, Mao X, Ortiz B, Mannent LP, Laws E, Ruddy M, Pandit-Abid N, Jacob-Nara JA, Gall R, Rowe PJ, Deniz Y, Lederer DJ, Hardin M. Sher LD, et al. Chest. 2022 Jul;162(1):46-55. doi: 10.1016/j.chest.2022.01.071. Epub 2022 Feb 22. Chest. 2022. PMID: 35217003 Clinical Trial.